Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & PerspectivesShorts
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm

Advertisement

Articles by Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm

PINNACLE trial aims to confirm pilot success with BPH drug-coated balloon catheter

ByJason M. Broderick and Cheryl Guttman Krader, BS, Pharm
August 3rd 2020

The drug-coated balloon catheter system is being compared with a sham device in a double-blinded randomized trial.

Advertisement

Latest Updated Articles

  • PINNACLE trial aims to confirm pilot success with BPH drug-coated balloon catheter
    PINNACLE trial aims to confirm pilot success with BPH drug-coated balloon catheter

    August 3rd 2020



Advertisement
Advertisement

Trending on Urology Times

1

Datopotamab deruxtecan enters phase 3 trial in high-risk muscle-invasive urothelial cancer

2

Pearls & Perspectives: From Emergency Medicine to Sexual Medicine, With Jeff Myers, DO

3

Nicole L. Miller, MD, FACS, on persistent LUTS after BPH treatment

4

AI system links surgical gestures with postoperative outcomes

5

Metabolic syndrome frequent during first year of ADT-ARPI therapy for prostate cancer

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us